Mutual Fund Details

ITI Pharma and Healthcare Fund Direct - Growth

Name: ITI Pharma and Healthcare Fund Direct - Growth
Brand: ITI Mutual Fund

Equity Pharma

NAV

₹18.1719

as on 17 Dec 2024, 11:25 PM

₹-0.0563(0.31%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,74,189

₹1,85,259

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹85,259

Profit (absolute return)

85.26%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

0.44%

In the last 6 months

21.88%

In the last 1 year

45.82%

In the last 3 years

85.26%

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

ITI Pharma and Healthcare Fund Direct - Growth

as of 30 Nov 2024, 05:30 AM

₹217.92 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 12 months.

0.47%

Expense Ratio

Plan

Growth

4.74%

Cash Holding

Benchmark

NIFTY Healthcare Total Return Index.

Scheme Document

View

Benchmark

NIFTY Healthcare Total Return Index.

Exit Load

Exit load of 1% if redeemed within 12 months.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

92.73%

₹202.07 Cr

Insurance

1.39%

₹3.03 Cr

Chemicals

1.14%

₹2.48 Cr

Others

4.74%

₹10.33 Cr

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

92.73%

₹202.07 Cr

Insurance

1.39%

₹3.03 Cr

Chemicals

1.14%

₹2.48 Cr

Others

4.74%

₹10.33 Cr

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.57%

₹33.93 Cr

Dr. Reddy's Laboratories Ltd.

7.53%

₹16.41 Cr

Lupin Ltd.

5.97%

₹13.01 Cr

Apollo Hospitals Enterprise Ltd.

5.81%

₹12.66 Cr

Suven Pharmaceuticals Ltd.

5.44%

₹11.85 Cr

Others

59.68%

₹130.05 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

15.57%

₹33.93 Cr

Dr. Reddy's Laboratories Ltd.

7.53%

₹16.41 Cr

Lupin Ltd.

5.97%

₹13.01 Cr

Apollo Hospitals Enterprise Ltd.

5.81%

₹12.66 Cr

Suven Pharmaceuticals Ltd.

5.44%

₹11.85 Cr

Others

59.68%

₹130.05 Cr

View All

Funds in this Category

This fund's returns:

23.19%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

DSP Healthcare Fund Direct - Growth

About ITI Pharma and Healthcare Fund Direct - Growth

ITI Pharma and Healthcare Fund Direct - Growth is a Equity mutual fund scheme from ITI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹217.92 Crores and the latest NAV decalared is ₹18.172 as on 18 Dec 2024 at 12:35 pm.

ITI Pharma and Healthcare Fund Direct - Growth scheme return performance in last 1 year is 45.82%, in last 3 years is 85.26% and 81.62% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.